Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease

Molecular Neurobiology ◽

10.1007/s12035-016-9921-3 ◽

2016 ◽

Vol 54 (5) ◽

pp. 3428-3438 ◽

Cited By ~ 27

Author(s):

Juan Jose Ramos-Rodriguez ◽

Tara Spires-Jones ◽

Amy M. Pooler ◽

Alfonso Maria Lechuga-Sancho ◽

Brian J. Bacskai ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Type 2 Diabetes ◽

Alzheimer's Disease ◽

Mouse Model ◽

Synaptic Loss ◽

Neuronal Pathology

P3-423: Liraglutide, a novel drug to treat type 2 diabetes, prevents the impairment of learning and hippocampal synaptic plasticity in an APP/PS-1 mouse model of Alzheimer's disease

Alzheimer s & Dementia ◽

10.1016/j.jalz.2010.05.1966 ◽

2010 ◽

Vol 6 ◽

pp. S577-S577

Author(s):

Christian Holscher ◽

Vadivel Parthsarathy ◽

Victor A. Gault ◽

Paula L. McClean

Keyword(s):

Alzheimer’S Disease ◽

Type 2 Diabetes ◽

Alzheimer's Disease ◽

Synaptic Plasticity ◽

Mouse Model ◽

Hippocampal Synaptic Plasticity ◽

Novel Drug

Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes

Molecular Neurobiology ◽

10.1007/s12035-017-0825-7 ◽

2017 ◽

Vol 55 (7) ◽

pp. 6130-6144 ◽

Cited By ~ 10

Author(s):

Carmen Infante-Garcia ◽

Juan Jose Ramos-Rodriguez ◽

Carmen Hierro-Bujalance ◽

Esperanza Ortegon ◽

Eleanor Pickett ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Type 2 Diabetes ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Mixed Model ◽

Central Pathology

Neuroprotective effects of salvianolic acid B on an Aβ25–35 peptide-induced mouse model of Alzheimer's disease

European Journal of Pharmacology ◽

10.1016/j.ejphar.2013.02.015 ◽

2013 ◽

Vol 704 (1-3) ◽

pp. 70-77 ◽

Cited By ~ 68

Author(s):

Young Woo Lee ◽

Dong Hyun Kim ◽

Su Jin Jeon ◽

Se Jin Park ◽

Jong Min Kim ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Salvianolic Acid B ◽

Neuroprotective Effects ◽

Salvianolic Acid ◽

Neuroprotective effects of salidroside administration in a mouse model of Alzheimer's disease

Molecular Medicine Reports ◽

10.3892/mmr.2018.8757 ◽

2018 ◽

Cited By ~ 4

Author(s):

Qingyun Li ◽

Jinhua Wang ◽

Yuwang Li ◽

Xiaolin Xu

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Neuroprotective Effects ◽

Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease

Neuropharmacology ◽

10.1016/j.neuropharm.2012.06.048 ◽

2013 ◽

Vol 64 ◽

pp. 124-136 ◽

Cited By ~ 53

Author(s):

Annerieke S.R. Sierksma ◽

Kris Rutten ◽

Sebastian Sydlik ◽

Somayeh Rostamian ◽

Harry W.M. Steinbusch ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Phosphodiesterase Type

Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer’s disease via activation of adenosine A1 receptor

Neuroscience Letters ◽

10.1016/j.neulet.2020.135016 ◽

2020 ◽

Vol 730 ◽

pp. 135016 ◽

Cited By ~ 1

Author(s):

Yanying Kong ◽

Qiuju Peng ◽

Nan Lv ◽

Jin Yuan ◽

Zhirong Deng ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Transgenic Mouse ◽

Transgenic Mouse Model ◽

Adenosine A1 Receptor ◽

Neuroprotective Effects ◽

Adenosine A1 ◽

A1 Receptor

Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer’s Disease via Inhibition of Nuclear Factor-Kappa B

Frontiers in Aging Neuroscience ◽

10.3389/fnagi.2019.00287 ◽

2019 ◽

Vol 11 ◽

Cited By ~ 2

Author(s):

Hyeon Joo Ham ◽

Ji Hye Han ◽

Yong Sun Lee ◽

Ki Cheon Kim ◽

Jaesuk Yun ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Phospholipase A2 ◽

Nuclear Factor Kappa B ◽

Bee Venom ◽

Nuclear Factor ◽

Neuroprotective Effects ◽

Nuclear Factor Kappa ◽

Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease

BMC Neuroscience ◽

10.1186/s12868-018-0406-3 ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 36

Author(s):

Panchanan Maiti ◽

Leela Paladugu ◽

Gary L. Dunbar

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Neuroprotective Effects ◽

Solid Lipid ◽

5Xfad Mouse ◽

Anti Inflammatory

Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes

Alzheimer s Research & Therapy ◽

10.1186/s13195-020-00607-4 ◽

2020 ◽

Vol 12 (1) ◽

Cited By ~ 2

Author(s):

Carmen Hierro-Bujalance ◽

Carmen Infante-Garcia ◽

Angel del Marco ◽

Marta Herrera ◽

Maria Jose Carranza-Naval ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Type 2 Diabetes ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Murine Model ◽

Vascular Damage ◽